表紙
市場調查報告書
商品編碼
1064941

全球藥物隔離器市場:按類型、應用、最終用戶機會分析/行業預測(2022-2030 年)

Pharmaceutical Isolator Market by Type, by Application and by End User - Global Opportunity Analysis and Industry Forecast 2022-2030.

出版日期: | 出版商: Next Move Strategy Consulting | 英文 290 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2021 年,全球藥物隔離器市場規模達到 16.2 億美元。從 2022 年到 2030 年,該市場的複合年增長率將保持在 11.1%,預計到 2030 年將達到 41.7 億美元。在全球範圍內,醫藥隔離器行業呈爆炸式增長,醫藥行業是主要的市場驅動力。此外,低運營成本是市場增長的驅動因素。

冠狀病毒的爆發已在全球範圍內造成健康危害,並顯著增加了對藥物的需求。預計對藥品的需求增加將推動對製藥技術隔離器的需求,並在預測期內導致市場擴張。

本報告調查了全球藥物隔離器市場,並提供了有關市場規模、市場動態、按細分市場/地區進行的市場分析、競爭格局和主要公司概況的信息。

目錄

第一章介紹

第 2 章藥物隔離器市場執行摘要

  • 市場快照(2021-2030 年,金額)

第三章市場概述

  • 市場定義和範圍
  • 市場動態
    • 促進因素
    • 抑制器
    • 市場機會

第四章市場份額分析

  • 主要供應商的市場份額分析(2021 年)
  • 安裝在隔離器中的機器人(單元)
  • 每年銷售的隔離器數量

第 5 章按系統類型:全球藥物隔離器市場

  • 概覽
  • 打開隔離器
  • 封閉式隔離器

第 6 章按用途:全球藥物隔離器市場

  • 概覽
  • 收容隔離器
  • 流體點膠隔離器
  • 採樣/公制隔離器
  • 生物隔離器
  • 其他

第 7 章最終用戶:全球藥物隔離器市場

  • 概覽
  • 研究/學術實驗室
  • 醫院
  • 製藥和生物技術

第 8 章按佈局:全球藥物隔離器市場

  • 概覽
  • 地板放置
  • 手機
  • 桌面

第 9 章區域:全球藥物隔離器市場

  • 概覽
  • 北美
  • 歐洲
  • 亞太地區
  • 其他領域

第 10 章公司簡介

  • COMECER S.P.A.
  • SKAN AG
  • ROBERT BOSCH GMBH
  • TEMA SINERGIE S.P.A.
  • GETINGE AB.
  • AZBIL TELSTAR, S.L.
  • JCE BIOTECHNOLOGY
  • DECK USA
  • HOSOKAWA MICRON LTD
  • ESCO TECHNOLOGIES, INC.
目錄

Market Definition:

The Pharmaceutical Isolator Market was valued at USD 1.62 billion in 2021 and is predicted to reach USD 4.17 billion by 2030 with a CAGR of 11.1% from 2022-2030. Pharmaceutical isolators are created with the goal of preventing contamination throughout the manufacturing process and other product handling operations. The pharmaceutical isolator protects the operator from drug exposure, eliminates the risk of cross-contamination, and ensures that the medication quality requirement is met. Maintaining utmost vigilance during the product manufacturing process is critical in the pharmaceutical isolator sector. Different types of isolators available on the pharmaceutical market ensure the highest level of sterility during the manufacturing process.

Market Dynamics and Trends

In the worldwide economy, the pharmaceutical isolator industry is exploding, and the pharmaceutical sector is the key driver of the market.

Low operational costs are another effective driver of pharmaceutical isolator market growth. Pharmaceutical isolator vendors sell isolators to pharmaceutical companies for a fraction of the cost of standard clean rooms. Operator intervention has the potential to contaminate the cleaned and disinfected clean rooms. The pharmaceutical isolator industry, on the other hand, keeps contamination to a minimum and maintains a bio-decontaminated environment in which only the medicine and production material come into touch with the complete processing system.

Cleaning the working space with hydrogen peroxide resulted in a bio-decontaminated environment inside the isolator. The automated bio-decontamination method allows for large quantities of disinfectant to be applied repeatedly in the pharmaceutical isolator's interior. The sterility assurance level (SAL) is much greater than that of sanitized clean rooms, driving the pharmaceutical isolator market.

However, the onset of the COVID19 pandemic had a significant influence on the pharmaceutical isolator business, acting as a major restrain to market expansion. Industries' manufacturing processes were halted for an unknown period of time. During the epidemic, the world economy suffered a hit. Even in the midst of the crisis, however, the market continued to rise. According to WHO, there have been 404,910,528 confirmed cases of COVID-19 recorded to WHO as of February 11, 2022, with 5,783,776 deaths. A total of 10,095,615,243 vaccine doses has been provided as of February 6, 2022. The coronavirus outbreak has sparked a global health disaster, and demand for pharmaceuticals has increased significantly. The rising demand for pharmaceuticals has boosted demand for pharmaceutical technology isolators, resulting in market expansion throughout the predicted period.

Market Segmentations and Scope of the Study

The pharmaceutical isolator market is segmented on the basis of type, pressure, application, end user and geography. By type, the market is further classified into open isolator and closed isolator. By pressure, the market is classified into positive pressure and negative pressure. By application, the is divided into aseptic isolators, containment isolators, sampling/weighing/distribution isolators, fluid dispensing isolators, and others. By end user, the market is divided into hospitals, pharmaceutical & biotechnology companies, research & academic laboratories, others. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and ROW.

Geographical Analysis

North America is likely to dominate the global pharmaceutical isolators market, due to the rapid adoption of innovative healthcare items, demanding regulatory and inspection models. Furthermore, rapidly rising market growth in this region has been attributed to the increasing concentration on vaccine and drug discovery and development.

However, the pharmaceutical isolator market, is predicted to grow at the fastest rate in Asia Pacific. This is due to an increasing pace of technological developments in biotechnology and pharmaceutical research in this region.

Competitive Landscape

The pharmaceutical isolator market comprising of various market players such as Getinge AB, Chiyoda Corporation, Azbil Corporation, Germfree, MBRAUN, Wabash National Corporation, NuAire, ITECO s.r.l., COMECER S.p.A., Hosokawa, Hecht Technologie GmbH, Steriline S.r.l., Envair Limited, Vanrx Pharmasystems Inc., TEMA SINERGIE S.p.A, SKAN AG, Bioquell Inc., I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A., JACOMEX, Fedegari Autoclavi S.p.A among others. These market players are adopting various strategies and planning expansion of business across various regions to maintain their dominance in the pharmaceutical isolator market. For instance, in May 2018, in the very competitive Best Health Care & Pharmaceutical PLC category of the renowned UK Stock Market awards, one of the leading global experts in decreasing the risk of bio-contamination in the life science, healthcare, and pharmaceutical markets has been shortlisted.

KEY MARKET SEGMENTS

Pharmaceutical Isolator Market- by Type

  • Open Isolator
  • Closed Isolator

Pharmaceutical Isolator Market- by Pressure

  • Positive Pressure
  • Negative Pressure

Pharmaceutical Isolator Market- by Application

  • Aseptic Isolators
  • Containment Isolators
  • Sampling/Weighing/Distribution Isolators
  • Fluid Dispensing Isolators
  • Others

Pharmaceutical Isolator Market- by End User

  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Laboratories
  • Others

Pharmaceutical Isolator Market- by Geography

  • North America
    • U.S
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • RoW
    • UAE
    • Saudi Arabia
    • South Africa
    • Brazil
    • Remaining countries

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. WHO SHOULD READ THIS REPORT
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. KEY MARKET PLAYERS
  • 1.5. RESEARCH METHODOLOGY
    • 1.5.1 SECONDARY RESEARCH
    • 1.5.2 DATA ANALYSIS FRAMEWORK
    • 1.5.3 MARKET SIZE ESTIMATION
    • 1.5.4 FORECASTING
    • 1.5.5 PRIMARY RESEARCH AND DATA VALIDATION

2. PHARMACEUTICAL ISOLATORS MARKET - EXECUTIVE SUMMARY

  • 2.1. MARKET SNAPSHOT, 2021 - 2030, MILLION USD

3. MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. MARKET DYNAMICS
    • 3.2.1 DRIVERS
      • 3.2.1.1. Increasing Prevalence of Cancer and Growing Demand for Biologic Products Worldwide is Anticipated to Propel the Market Growth
      • 3.2.1.2. Rise in pharmaceutical companies and contract research organizations
    • 3.2.2 RESTRAINTS
      • 3.2.2.1. High cost associated with the pharmaceutical isolator system
      • 3.2.2.2. Stringent regulatory guidelines for the approval of parenteral products
    • 3.2.3 OPPORTUNITIES
      • 3.2.3.1. Rise in need for strategic alliances to support the mid- and small-sized pharmaceutical companies and CROS

4. MARKET SHARE ANALYSIS

  • 4.1. MARKET SHARE ANALYSIS OF TOP PHARMACEUTICAL ISOLATORS PROVIDERS, 2021
  • 4.2. ROBOT INSTALLED WITHIN ISOLATOR (UNITS)
  • 4.3. NUMBER OF ISOLATOR SOLD PER YEAR

5. GLOBAL PHARMACEUTICAL ISOLATORS MARKET, BY SYSTEM TYPE

  • 5.1. OVERVIEW
  • 5.2. OPEN ISOLATOR
    • 5.2.1 OPEN ISOLATOR MARKET, BY REGION
      • 5.2.1.1 North America Open Isolator Market, By Country
      • 5.2.1.2 Europe Open Isolator Market, By Country
      • 5.2.1.3 Asia-Pacific Open Isolator Market, By Country
      • 5.2.1.4 Rest of the World Open Isolator Market, By Country
  • 5.3. CLOSED ISOLATOR
    • 5.3.1 CLOSED ISOLATOR MARKET, BY REGION
      • 5.3.1.1 North America Closed Isolator Market, By Country
      • 5.3.1.2 Europe Closed Isolator Market, By Country
      • 5.3.1.3 Asia-Pacific Closed Isolator Market, By Country
      • 5.3.1.4 Rest of the World Closed Isolator Market, By Country

6. GLOBAL PHARMACEUTICAL ISOLATORS MARKET, BY USAGE

  • 6.1. OVERVIEW
  • 6.2. CONTAINMENT ISOLATOR
    • 6.2.1 CONTAINMENT ISOLATOR MARKET, BY REGION
      • 6.2.1.1 North America Containment Isolator Market, By Country
      • 6.2.1.2 Europe Containment Isolator Market, By Country
      • 6.2.1.3 Asia-Pacific Containment Isolator Market, By Country
      • 6.2.1.4 Rest of the World Containment Isolator Market, By Country
  • 6.3. FLUID DISPENSING ISOLATOR
    • 6.3.1 FLUID DISPENSING ISOLATOR MARKET, BY REGION
      • 6.3.1.1 North America Fluid Dispensing Isolator Market, By Country
      • 6.3.1.2 Europe Fluid Dispensing Isolator Market, By Country
      • 6.3.1.3 Asia-Pacific Fluid Dispensing Isolator Market, By Country
      • 6.3.1.4 Rest of the World Fluid Dispensing Isolator Market, By Country
  • 6.4. SAMPLING/WEIGHING ISOLATORS
    • 6.4.1 SAMPLING/WEIGHING ISOLATORS MARKET, BY REGION
      • 6.4.1.1 North America Sampling/Weighing Isolators Market, By Country
      • 6.4.1.2 Europe Sampling/Weighing Isolators Market, By Country
      • 6.4.1.3 Asia-Pacific Sampling/Weighing Isolators Market, By Country
      • 6.4.1.4 Rest of the World Sampling/Weighing Isolators Market, By Country
  • 6.5. BIO ISOLATORS
    • 6.5.1 BIO ISOLATORS MARKET, BY REGION
      • 6.5.1.1 North America Bio Isolators Market, By Country
      • 6.5.1.2 Europe Bio Isolators Market, By Country
      • 6.5.1.3 Asia-Pacific Bio Isolators Market, By Country
      • 6.5.1.4 Rest of the World Bio Isolators Market, By Country
  • 6.6. OTHERS
    • 6.6.1 OTHERS MARKET, BY REGION
      • 6.6.1.1 North America Others Market, By Country
      • 6.6.1.2 Europe Others Market, By Country
      • 6.6.1.3 Asia-Pacific Others Market, By Country
      • 6.6.1.4 Rest of the World Others Market, By Country

7. GLOBAL PHARMACEUTICAL ISOLATORS MARKET, BY END-USER

  • 7.1. OVERVIEW
  • 7.2. RESEARCH & ACADEMICS LABS
    • 7.2.1 RESEARCH & ACADEMICS LABS MARKET, BY REGION
      • 7.2.1.1 North America Research & Academics Labs Market, By Country
      • 7.2.1.2 Europe Research & Academics Labs Market, By Country
      • 7.2.1.3 Asia-Pacific Research & Academics Labs Market, By Country
      • 7.2.1.4 Rest of the World Research & Academics Labs Market, By Country
  • 7.3. HOSPITALS
    • 7.3.1 HOSPITALS MARKET, BY REGION
      • 7.3.1.1 North America Hospitals Market, By Country
      • 7.3.1.2 Europe Hospitals Market, By Country
      • 7.3.1.3 Asia-Pacific Hospitals Market, By Country
      • 7.3.1.4 Rest of the World Hospitals Market, By Country
  • 7.4. PHARMACEUITCALS & BIOTECHNOLOGY
    • 7.4.1 PHARMACEUITCALS & BIOTECHNOLOGY MARKET, BY REGION
      • 7.4.1.1 North America Pharmaceuitcals & Biotechnology Market, By Country
      • 7.4.1.2 Europe Pharmaceuitcals & Biotechnology Market, By Country
      • 7.4.1.3 Asia-Pacific Pharmaceuitcals & Biotechnology Market, By Country
      • 7.4.1.4 Rest of the World Pharmaceuitcals & Biotechnology Market, By Country

8. GLOBAL PHARMACEUTICAL ISOLATORS MARKET, BY CONFIGURATION

  • 8.1. OVERVIEW
  • 8.2. FLOOR STANDING
    • 8.2.1 FLOOR STANDING MARKET, BY REGION
      • 8.2.1.1 North America Floor Standing Market, By Country
      • 8.2.1.2 Europe Floor Standing Market, By Country
      • 8.2.1.3 Asia-Pacific Floor Standing Market, By Country
      • 8.2.1.4 Rest of the World Floor Standing Market, By Country
  • 8.3. MOBILE
    • 8.3.1 MOBILE MARKET, BY REGION
      • 8.3.1.1 North America Mobile Market, By Country
      • 8.3.1.2 Europe Mobile Market, By Country
      • 8.3.1.3 Asia-Pacific Mobile Market, By Country
      • 8.3.1.4 Rest of the World Mobile Market, By Country
  • 8.4. TABLE TOP
    • 8.4.1 TABLE TOP MARKET, BY REGION
      • 8.4.1.1 North America Table Top Market, By Country
      • 8.4.1.2 Europe Table Top Market, By Country
      • 8.4.1.3 Asia-Pacific Table Top Market, By Country
      • 8.4.1.4 Rest of the World Table Top Market, By Country

9. GLOBAL PHARMACEUTICAL ISOLATORS MARKET, BY REGION

  • 9.1. OVERVIEW
  • 9.2. NORTH AMERICA
    • 9.2.1 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET, BY SYSTEM TYPE
    • 9.2.2 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET, BY USAGE
    • 9.2.3 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET, BY END-USER
    • 9.2.4 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET, BY CONFIGURATION
    • 9.2.5 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET, BY COUNTRY
      • 9.2.5.1 U.S.
        • 9.2.5.1.1 U.S. Pharmaceutical Isolators Market, By System Type
        • 9.2.5.1.2 U.S. Pharmaceutical Isolators Market, By Usage
        • 9.2.5.1.3 U.S. Pharmaceutical Isolators Market, By End-User
        • 9.2.5.1.4 U.S. Pharmaceutical Isolators Market, By Configuration
      • 9.2.5.2 Canada
        • 9.2.5.2.1 Canada Pharmaceutical Isolators Market, By System Type
        • 9.2.5.2.2 Canada Pharmaceutical Isolators Market, By Usage
        • 9.2.5.2.3 Canada Pharmaceutical Isolators Market, By End-User
        • 9.2.5.2.4 Canada Pharmaceutical Isolators Market, By Configuration
      • 9.2.5.3 Mexico
        • 9.2.5.3.1 Mexico Pharmaceutical Isolators Market, By System Type
        • 9.2.5.3.2 Mexico Pharmaceutical Isolators Market, By Usage
        • 9.2.5.3.3 Mexico Pharmaceutical Isolators Market, By End-User
        • 9.2.5.3.4 Mexico Pharmaceutical Isolators Market, By Configuration
  • 9.3. EUROPE
    • 9.3.1 EUROPE PHARMACEUTICAL ISOLATORS MARKET, BY SYSTEM TYPE
    • 9.3.2 EUROPE PHARMACEUTICAL ISOLATORS MARKET, BY USAGE
    • 9.3.3 EUROPE PHARMACEUTICAL ISOLATORS MARKET, BY END-USER
    • 9.3.4 EUROPE PHARMACEUTICAL ISOLATORS MARKET, BY CONFIGURATION
    • 9.3.5 EUROPE PHARMACEUTICAL ISOLATORS MARKET, BY COUNTRY
      • 9.3.5.1 UK
        • 9.3.5.1.1 UK Pharmaceutical Isolators Market, By System Type
        • 9.3.5.1.2 UK Pharmaceutical Isolators Market, By Usage
        • 9.3.5.1.3 UK Pharmaceutical Isolators Market, By End-User
        • 9.3.5.1.4 UK Pharmaceutical Isolators Market, By Configuration
      • 9.3.5.2 Germany
        • 9.3.5.2.1 Germany Pharmaceutical Isolators Market, By System Type
        • 9.3.5.2.2 Germany Pharmaceutical Isolators Market, By Usage
        • 9.3.5.2.3 Germany Pharmaceutical Isolators Market, By End-User
        • 9.3.5.2.4 Germany Pharmaceutical Isolators Market, By Configuration
      • 9.3.5.3 Italy
        • 9.3.5.3.1 Italy Pharmaceutical Isolators Market, By System Type
        • 9.3.5.3.2 Italy Pharmaceutical Isolators Market, By Usage
        • 9.3.5.3.3 Italy Pharmaceutical Isolators Market, By End-User
        • 9.3.5.3.4 Italy Pharmaceutical Isolators Market, By Configuration
      • 9.3.5.4 France
        • 9.3.5.4.1 France Pharmaceutical Isolators Market, By System Type
        • 9.3.5.4.2 France Pharmaceutical Isolators Market, By Usage
        • 9.3.5.4.3 France Pharmaceutical Isolators Market, By End-User
        • 9.3.5.4.4 France Pharmaceutical Isolators Market, By Configuration
      • 9.3.5.5 Netherland
        • 9.3.5.5.1 Netherland Pharmaceutical Isolators Market, By System Type
        • 9.3.5.5.2 Netherland Pharmaceutical Isolators Market, By Usage
        • 9.3.5.5.3 Netherland Pharmaceutical Isolators Market, By End-User
        • 9.3.5.5.4 Netherland Pharmaceutical Isolators Market, By Configuration
      • 9.3.5.6 Denmark
        • 9.3.5.6.1 Denmark Pharmaceutical Isolators Market, By System Type
        • 9.3.5.6.2 Denmark Pharmaceutical Isolators Market, By Usage
        • 9.3.5.6.3 Denmark Pharmaceutical Isolators Market, By End-User
        • 9.3.5.6.4 Denmark Pharmaceutical Isolators Market, By Configuration
      • 9.3.5.7 Finaland
        • 9.3.5.7.1 Finaland Pharmaceutical Isolators Market, By System Type
        • 9.3.5.7.2 Finaland Pharmaceutical Isolators Market, By Usage
        • 9.3.5.7.3 Finaland Pharmaceutical Isolators Market, By End-User
        • 9.3.5.7.4 Finaland Pharmaceutical Isolators Market, By Configuration
      • 9.3.5.8 Norway
        • 9.3.5.8.1 Norway Pharmaceutical Isolators Market, By System Type
        • 9.3.5.8.2 Norway Pharmaceutical Isolators Market, By Usage
        • 9.3.5.8.3 Norway Pharmaceutical Isolators Market, By End-User
        • 9.3.5.8.4 Norway Pharmaceutical Isolators Market, By Configuration
      • 9.3.5.9 Sweden
        • 9.3.5.9.1 Sweden Pharmaceutical Isolators Market, By System Type
        • 9.3.5.9.2 Sweden Pharmaceutical Isolators Market, By Usage
        • 9.3.5.9.3 Sweden Pharmaceutical Isolators Market, By End-User
        • 9.3.5.9.4 Sweden Pharmaceutical Isolators Market, By Configuration
      • 9.3.5.10 Russia
        • 9.3.5.10.1 Russia Pharmaceutical Isolators Market, By System Type
        • 9.3.5.10.2 Russia Pharmaceutical Isolators Market, By Usage
        • 9.3.5.10.3 Russia Pharmaceutical Isolators Market, By End-User
        • 9.3.5.10.4 Russia Pharmaceutical Isolators Market, By Configuration
      • 9.3.5.11 Rest of Europe
        • 9.3.5.11.1 Rest of Europe Pharmaceutical Isolators Market, By System Type
        • 9.3.5.11.2 Rest of Europe Pharmaceutical Isolators Market, By Usage
        • 9.3.5.11.3 Rest of Europe Pharmaceutical Isolators Market, By End-User
        • 9.3.5.11.4 Rest of Europe Pharmaceutical Isolators Market, By Configuration
  • 9.4. ASIA-PACIFIC
    • 9.4.1 ASIA-PACIFIC PHARMACEUTICAL ISOLATORS MARKET, BY SYSTEM TYPE
    • 9.4.2 ASIA-PACIFIC PHARMACEUTICAL ISOLATORS MARKET, BY USAGE
    • 9.4.3 ASIA-PACIFIC PHARMACEUTICAL ISOLATORS MARKET, BY END-USER
    • 9.4.4 ASIA-PACIFIC PHARMACEUTICAL ISOLATORS MARKET, BY CONFIGURATION
    • 9.4.5 ASIA-PACIFIC PHARMACEUTICAL ISOLATORS MARKET, BY COUNTRY
      • 9.4.5.1 China
        • 9.4.5.1.1 China Pharmaceutical Isolators Market, By System Type
        • 9.4.5.1.2 China Pharmaceutical Isolators Market, By Usage
        • 9.4.5.1.3 China Pharmaceutical Isolators Market, By End-User
        • 9.4.5.1.4 China Pharmaceutical Isolators Market, By Configuration
      • 9.4.5.2 India
        • 9.4.5.2.1 India Pharmaceutical Isolators Market, By System Type
        • 9.4.5.2.2 India Pharmaceutical Isolators Market, By Usage
        • 9.4.5.2.3 India Pharmaceutical Isolators Market, By End-User
        • 9.4.5.2.4 India Pharmaceutical Isolators Market, By Configuration
      • 9.4.5.3 Japan
        • 9.4.5.3.1 Japan Pharmaceutical Isolators Market, By System Type
        • 9.4.5.3.2 Japan Pharmaceutical Isolators Market, By Usage
        • 9.4.5.3.3 Japan Pharmaceutical Isolators Market, By End-User
        • 9.4.5.3.4 Japan Pharmaceutical Isolators Market, By Configuration
      • 9.4.5.4 Australia
        • 9.4.5.4.1 Australia Pharmaceutical Isolators Market, By System Type
        • 9.4.5.4.2 Australia Pharmaceutical Isolators Market, By Usage
        • 9.4.5.4.3 Australia Pharmaceutical Isolators Market, By End-User
        • 9.4.5.4.4 Australia Pharmaceutical Isolators Market, By Configuration
      • 9.4.5.5 South Korea
        • 9.4.5.5.1 South Korea Pharmaceutical Isolators Market, By System Type
        • 9.4.5.5.2 South Korea Pharmaceutical Isolators Market, By Usage
        • 9.4.5.5.3 South Korea Pharmaceutical Isolators Market, By End-User
        • 9.4.5.5.4 South Korea Pharmaceutical Isolators Market, By Configuration
      • 9.4.5.6 Singapore
        • 9.4.5.6.1 Singapore Pharmaceutical Isolators Market, By System Type
        • 9.4.5.6.2 Singapore Pharmaceutical Isolators Market, By Usage
        • 9.4.5.6.3 Singapore Pharmaceutical Isolators Market, By End-User
        • 9.4.5.6.4 Singapore Pharmaceutical Isolators Market, By Configuration
      • 9.4.5.7 Taiwan
        • 9.4.5.7.1 Taiwan Pharmaceutical Isolators Market, By System Type
        • 9.4.5.7.2 Taiwan Pharmaceutical Isolators Market, By Usage
        • 9.4.5.7.3 Taiwan Pharmaceutical Isolators Market, By End-User
        • 9.4.5.7.4 Taiwan Pharmaceutical Isolators Market, By Configuration
      • 9.4.5.8 Vietnam
        • 9.4.5.8.1 Vietnam Pharmaceutical Isolators Market, By System Type
        • 9.4.5.8.2 Vietnam Pharmaceutical Isolators Market, By Usage
        • 9.4.5.8.3 Vietnam Pharmaceutical Isolators Market, By End-User
        • 9.4.5.8.4 Vietnam Pharmaceutical Isolators Market, By Configuration
      • 9.4.5.9 Rest of Asia-Pacific
        • 9.4.5.9.1 Rest of Asia-Pacific Pharmaceutical Isolators Market, By System Type
        • 9.4.5.9.2 Rest of Asia-Pacific Pharmaceutical Isolators Market, By Usage
        • 9.4.5.9.3 Rest of Asia-Pacific Pharmaceutical Isolators Market, By End-User
        • 9.4.5.9.4 Rest of Asia-Pacific Pharmaceutical Isolators Market, By Configuration
  • 9.5. REST OF THE WORLD
    • 9.5.1 REST OF THE WORLD PHARMACEUTICAL ISOLATORS MARKET, BY SYSTEM TYPE
    • 9.5.2 REST OF THE WORLD PHARMACEUTICAL ISOLATORS MARKET, BY USAGE
    • 9.5.3 REST OF THE WORLD PHARMACEUTICAL ISOLATORS MARKET, BY END-USER
    • 9.5.4 REST OF THE WORLD PHARMACEUTICAL ISOLATORS MARKET, BY CONFIGURATION
    • 9.5.5 REST OF THE WORLD PHARMACEUTICAL ISOLATORS MARKET, BY COUNTRY
      • 9.5.5.1 Brazil
        • 9.5.5.1.1 Brazil Pharmaceutical Isolators Market, By System Type
        • 9.5.5.1.2 Brazil Pharmaceutical Isolators Market, By Usage
        • 9.5.5.1.3 Brazil Pharmaceutical Isolators Market, By End-User
        • 9.5.5.1.4 Brazil Pharmaceutical Isolators Market, By Configuration
      • 9.5.5.2 South Africa
        • 9.5.5.2.1 South Africa Pharmaceutical Isolators Market, By System Type
        • 9.5.5.2.2 South Africa Pharmaceutical Isolators Market, By Usage
        • 9.5.5.2.3 South Africa Pharmaceutical Isolators Market, By End-User
        • 9.5.5.2.4 South Africa Pharmaceutical Isolators Market, By Configuration
      • 9.5.5.3 Nigeria
        • 9.5.5.3.1 Nigeria Pharmaceutical Isolators Market, By System Type
        • 9.5.5.3.2 Nigeria Pharmaceutical Isolators Market, By Usage
        • 9.5.5.3.3 Nigeria Pharmaceutical Isolators Market, By End-User
        • 9.5.5.3.4 Nigeria Pharmaceutical Isolators Market, By Configuration
      • 9.5.5.4 Israel
        • 9.5.5.4.1 Israel Pharmaceutical Isolators Market, By System Type
        • 9.5.5.4.2 Israel Pharmaceutical Isolators Market, By Usage
        • 9.5.5.4.3 Israel Pharmaceutical Isolators Market, By End-User
        • 9.5.5.4.4 Israel Pharmaceutical Isolators Market, By Configuration
      • 9.5.5.5 KSA
        • 9.5.5.5.1 KSA Pharmaceutical Isolators Market, By System Type
        • 9.5.5.5.2 KSA Pharmaceutical Isolators Market, By Usage
        • 9.5.5.5.3 KSA Pharmaceutical Isolators Market, By End-User
        • 9.5.5.5.4 KSA Pharmaceutical Isolators Market, By Configuration
      • 9.5.5.6 Turkey
        • 9.5.5.6.1 Turkey Pharmaceutical Isolators Market, By System Type
        • 9.5.5.6.2 Turkey Pharmaceutical Isolators Market, By Usage
        • 9.5.5.6.3 Turkey Pharmaceutical Isolators Market, By End-User
        • 9.5.5.6.4 Turkey Pharmaceutical Isolators Market, By Configuration
      • 9.5.5.7 Remaining Countries
        • 9.5.5.7.1 Remaining Countries Pharmaceutical Isolators Market, By System Type
        • 9.5.5.7.2 Remaining Countries Pharmaceutical Isolators Market, By Usage
        • 9.5.5.7.3 Remaining Countries Pharmaceutical Isolators Market, By End-User
        • 9.5.5.7.4 Remaining Countries Pharmaceutical Isolators Market, By Configuration

10. COMPANY PROFILES

  • 10.1. COMECER S.P.A.
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 COMPANY SNAPSHOT
    • 10.1.3 PRODUCT PORTFOLIO
    • 10.1.4 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 10.1.5 PRIMARY MARKET COMPETITORS
  • 10.2. SKAN AG
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 COMPANY SNAPSHOT
    • 10.2.3 PRODUCT PORTFOLIO
    • 10.2.4 BUSINESS PERFORMANCE
    • 10.2.1 SALES BY BUSINESS SEGMENT
    • 10.2.2 PRIMARY MARKET COMPETITORS
  • 10.3. ROBERT BOSCH GMBH
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 COMPANY SNAPSHOT
    • 10.3.3 PRODUCT PORTFOLIO
    • 10.3.4 BUSINESS PERFORMANCE
    • 10.3.5 SALES BY BUSINESS SEGMENT
    • 10.3.6 SALES BY GEOGRAPHIC SEGMENT
    • 10.3.7 PRIMARY MARKET COMPETITORS
  • 10.4. TEMA SINERGIE S.P.A.
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 COMPANY SNAPSHOT
    • 10.4.3 PRODUCT PORTFOLIO
    • 10.4.4 BUSINESS PERFORMANCE
    • 10.4.5 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 10.4.6 PRIMARY MARKET COMPETITORS
  • 10.5. GETINGE AB.
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 COMPANY SNAPSHOT
    • 10.5.3 PRODUCT PORTFOLIO
    • 10.5.4 BUSINESS PERFORMANCE
    • 10.5.5 SALES BY BUSINESS SEGMENT
    • 10.5.6 SALES BY GEOGRAPHIC SEGMENT
    • 10.5.7 PRIMARY MARKET COMPETITORS
  • 10.6. AZBIL TELSTAR, S.L.
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 COMPANY SNAPSHOT
    • 10.6.3 PRODUCT PORTFOLIO
    • 10.6.4 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 10.6.5 PRIMARY MARKET COMPETITORS
  • 10.7. JCE BIOTECHNOLOGY
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 COMPANY SNAPSHOT
    • 10.7.3 PRODUCT PORTFOLIO
    • 10.7.4 KEY STRATEGIC MOVES & DEVELOPMENTS
    • 10.7.5 PRIMARY MARKET COMPETITORS
  • 10.8. DECK USA
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 COMPANY SNAPSHOT
    • 10.8.3 PRODUCT PORTFOLIO
    • 10.8.4 PRIMARY MARKET COMPETITORS
  • 10.9. HOSOKAWA MICRON LTD
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 COMPANY SNAPSHOT
    • 10.9.3 PRODUCT PORTFOLIO
    • 10.9.4 BUSINESS PERFORMANCE
    • 10.9.5 SALES BY BUSINESS SEGMENT
    • 10.9.6 SALES BY GEOGRAPHIC SEGMENT
    • 10.9.7 PRIMARY MARKET COMPETITORS
  • 10.10. ESCO TECHNOLOGIES, INC.
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 COMPANY SNAPSHOT
    • 10.10.3 PRODUCT PORTFOLIO
    • 10.10.4 BUSINESS PERFORMANCE
    • 10.10.5 SALES BY BUSINESS SEGMENT
    • 10.10.6 SALES BY GEOGRAPHIC SEGMENT
    • 10.10.7 PRIMARY MARKET COMPETITORS